Formosa Laboratories, Inc.

About Us

Product & Service

Facilities

Quality & Compliance

For Investors

Career

About Us

News

2023-08-25

US Patent No.US11,731,998 B2 entitled METHOD OFPREPARINGFERRIC
CARBOXYMALTOSE was granted on Aug 22, 2023.

2023-02-22

Formosalab receives TFDA approval for Eribulin Mesylate injectable

2022-12-08

TW Patent No. I784646 entitled METHOD FOR PREPARING FERRIC CARBOXYMALTOSE was granted on Nov 21, 2022.

2022-11-15

Formosa Labs’ fermentation production line was successfully inspected by US FDA in November 2022.

2022-11-08

TW Patent No. I781345 entitled Crystalline form of Baricitinib and method for preparation thereof was granted on Oct 21, 2022.

2022-11-07

Formosa has won the Talent Quality-management System (TTQS) Bronze Medal Award.

2022-06-21

Formosa Injectable plant passed GMP/GDP inspection by TFDA.(Jun. 15, 2022)

2021-11-11

Passed GDP inspection by TFDA for medicinal products. (Sep. 27th, 2021)

2021-11-11

Passed GMP inspection by TFDA for packaging and labeling of medicinal products. (Sep. 15th, 2021)

2021-06-01

US Patent No.US11,021,483 entitled Crystalline of camphorsulfonic acid salt of Rucaparib and method of preparing of tricyclic compounds, Rucaparib and crystalline of camphorsulfonic acid salt of Rucaparib was granted on June 1, 2021.

丙肝